1. U.S. makes deal for 100 million doses of coronavirus vaccine, deaths expected to rise  The Star Online
  2. US pledges up to US$2.1 billion for Sanofi, GlaxoSmithKline COVID-19 vaccine  The Edge Markets MY
  3. GSK on $2.1B vaccine supply deal with U.S.  CNBC Television
  4. Sanofi, Glaxo advance talks to supply up to 300 million COVID-19 vaccine doses to Europe - companies  The Star Online
  5. EU poised to secure Sanofi deal for coronavirus vaccine  The Edge Markets MY
  6. View Full coverage on Google News
(Reuters) - Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.(Reuters) - Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.

U.S. makes deal for 100 million doses of coronavirus vaccine, deaths expected to rise | The Star

The European Commission said it would allow all 27 member countries to purchase the vaccineThe European Commission said it would allow all 27 member countries to purchase the vaccine

EU reserves 300m doses of potential Sanofi virus vaccine - Health - Dunya News

EU reserves 300m doses of potential Sanofi virus vaccine

The United States will pay Sanofi and GlaxoSmithKline up to $2.1 billion to test and produce 100 million doses of an experimental coronavirus vaccine.The United States will pay Sanofi and GlaxoSmithKline up to $2.1 billion to test and produce 100 million doses of an experimental coronavirus vaccine.

$2.1 billion Sanofi/GSK deal for 100 million coronavirus vaccine doses

The U.S. government will pay $2.1 billion to drugmakers Glaxo and Sanofi for the production of COVID-19 vaccines for up to 50 million people, tests and treatments, the companies announced Friday.It's the largest grant that's been given under the Trump administration's "Operation Warp Speed," the White House initiative focused on producing an accessible coronavirus vaccine by the end of the year. The deal covers 100 million vaccines, at two per...

US pledges $2.1 billion to Glaxo, Sanofi for coronavirus vaccine

"You can't have a contractor supervising government officials.""You can't have a contractor supervising government officials."

Trump's Vaccine Chief Picks His Own Former Employer—Where He Still Holds Millions Worth of Stock—for $2.1 Billion Deal | Common Dreams News

Executives with pharma ties are exempt from disclosing conflicts.

Vaccine project contract raises transparency questions - POLITICO

The U.S. government has promised $7.9 billion to secure hundreds of millions of doses of these SARS-CoV-2 vaccine candidates.The U.S. government has promised $7.9 billion to secure hundreds of millions of doses of these SARS-CoV-2 vaccine candidates.

5 Coronavirus Vaccines With Huge Operation Warp Speed Deals | The Motley Fool

The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.

Sanofi, GSK reach COVID-19 vaccine deals with US, EU - CNA

Pharma giants GlaxoSmithKline and Sanofi Pasteur will supply 100 million doses of potential COVID-19 vaccine to the US.Pharma giants GlaxoSmithKline and Sanofi Pasteur will supply 100 million doses of potential COVID-19 vaccine to the US.

US to sink up to another $2.1bn for potential COVID-19 vaccine | Coronavirus pandemic News | Al Jazeera

The US government invested $2.1 billion in the development and delivery of 100 million doses of the vaccine candidate from Sanofi and GlaxoSmithKline on Friday. This is the second multi-billion dollar contract the US has made this month, following a $1.The US government invested $2.1 billion in the development and delivery of 100 million doses of the vaccine candidate from Sanofi and GlaxoSmithKline on Friday. This is the second multi-billion dol…

The US government just spent $2.1 billion on its biggest coronavirus vaccine contract yet – BGR

Bloomberg - Are you a robot?

The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.

EU reserves 300 mn doses of potential Sanofi virus vaccine

The deal appears to price the vaccine at less than $10.50 a dose.The deal appears to price the vaccine at less than $10.50 a dose.

Glaxo and Sanofi Will Sell 100 Million Covid-19 Vaccine Doses to the U.S. - Barron's

The contract is the largest yet from the U.S. government.The contract is the largest yet from the U.S. government.

European drugmakers Sanofi and GSK strike $2.1 billion deal with U.S. for a coronavirus vaccine - The Washington Post

Sanofi recently moved up the date of its first clinical trial to September. Companies like Moderna's have already reached phase 3.Sanofi recently moved up the date of its first clinical trial to September. Companies like Moderna's have already reached phase 3.

Sanofi GSK coronavirus vaccine gets funded by Operation Warp Speed - Business Insider

Pharma giants Sanofi and GSK will receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus ...

US to put up $2.1 bn for Sanofi, GSK coronavirus vaccine

The United States has agreed a $2.1bn (£1.6bn) deal with two big pharmaceutical companies to produce 100 million doses of an experimental Covid-19 vaccine. British pharmaceutical giant GlaxoSmithKline and French counterpart Sanofi Pasteur announced the agreement with the US government on Friday.  The deal is believed to be the largest such agreement to date, as countries startThe United States has agreed a $2.1bn (£1.6bn) deal with two big pharmaceutical companies to produce 100 million doses of an experimental Covid-19 vaccine. British pharmaceutical giant

Coronavirus vaccine: US seals $2.1bn deal with drug companies for 100 million doses | The Independent

The head of the government’s effort to develop a vaccine against Covid-19 says he expects the vaccine to have efficacy rates “in the 90%” range — but that there might not be enough vaccines available for all Americans until the end of next year. “I think it will be a very effective vaccine. That’s my […]The head of the government’s effort to develop a vaccine against Covid-19 says he expects the vaccine to have efficacy rates “in the 90%” range — but that there might not be…

Operation Warp Speed leader predicts effectiveness of coronavirus vaccine to be ‘in the 90%’ range | KTLA

The head of the government’s effort to develop a vaccine against Covid-19 says he expects the vaccine to have efficacy rates “in the 90%” range — but that there might not be…

Operation Warp Speed leader predicts effectiveness of coronavirus vaccine to be ‘in the 90%’ range | KTLA

LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2. 1 billion "for development including clinical trials, manufacturing, scale-up and delivery" of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds. The U. S.LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2. 1 billion "for development including clinical trials, manufacturing, scale-up and delivery" of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds. The U. S.

US sinks another $2.1 billion into a potential vaccine | KECI

US sinks another $2.1 billion into a potential vaccine

This is the country’s biggest Covid-19 vaccine deal yet.This is the country’s biggest Covid-19 vaccine deal yet.

U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 Vaccine

404 Not Found

BRUSSELS, Belgium (AFP) — The European Union announced Friday that it had struck a deal wit...BRUSSELS, Belgium (AFP) — The European Union announced Friday that it had struck a deal wit...

EU reserves 300 million doses of potential Sanofi virus vaccine

You have been blocked

Sanofi to set aside 300 million doses of potential coronavirus vaccine for 27 EU membersThe European Union announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine. The European...

Sanofi to set aside 300 million doses of potential coronavirus vaccine for 27 EU members | Daily Sabah

The firms aim to combine a Sanofi-developed antigen, which stimulates the production of germ-killing antibodies, with GSK's adjuvant technology, a substance that bolsters the immune response triggered by a vaccineThe firms aim to combine a Sanofi-developed antigen, which stimulates the production of germ-killing antibodies, with GSK's adjuvant technology, a substance that bolsters the immune response triggered by a vaccine

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

The European Union has announced that a deal has been reached between them and pharmaceutical company Sanofi, for the provision of 300 million doses of the potential COVID-19 vaccination The exploratory talks included terms of an envisaged contract that would allow EU Member States to purchase the required number of doses for their respective countries.

EC Reaches Agreement to Purchase 300 Million Future COVID-19 Vaccines - Exit - Explaining Albania

Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a commitment from the U.S. federal government to pay up to $2.1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a commitment from the U.S. federal government to pay up to $2.1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.

Two drug giants to partner on US$2B coronavirus vaccine contract | CTV News

The US government will provide drugmakers GlaxoSmithKline (GSK) and Sanofi $2.1 billion for the production of COVID-19 vaccines for up to 50 million people, the...The US government will provide drugmakers GlaxoSmithKline (GSK) and Sanofi $2.1 billion for the production of COVID-19 vaccines for up to 50 million people, the...

US Pledges $2.1 Billion to Two Drugmakers in Biggest Grant Yet for COVID-19 Vaccine - Sputnik International

The European Union has reached an agreement with French pharmaceutical giant Sanofi for the supply of 300 million doses of a potential coronavirus vaccine.The European Union has reached an agreement with French pharmaceutical giant Sanofi for the supply of 300 million doses of a potential coronavirus vaccine.

EU strikes deal with Sanofi for supply of potential COVID-19 vaccine | News | DW | 01.08.2020

Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.

COVID-19 Vaccine: US Makes Deal For 100 Million Doses Of COVID-19 Vaccine, Deaths Expected To Rise

The U.S. will pay up to $2.1 billion to Sanofi and GlaxoSmithKline to fund the development of a coronavirus vaccine and guarantee supply of 100 million doses, if proven safe and effective in clinical trials, the companies said.The U.S. will pay up to $2.1 billion to Sanofi and GlaxoSmithKline to fund the development of a coronavirus vaccine and guarantee supply of 100 million doses, if proven safe and effective in clinical trials, the companies said.

Sanofi, GlaxoSmithKline Ink Coronavirus Vaccine Deal With U.S. - WSJ

The U.S. government pledged $2.1 billion to pharmaceutical companies GlaxoSmithKline and Sanofi Pasteur for the production of up to 100 million doses of COVID-19 vaccines as well as tests and treatments.The U.S. government pledged $2.1 billion to pharmaceutical companies GlaxoSmithKline and Sanofi Pasteur for the production of up to 100 million doses of COVID-19 vaccines as well as tests and treatments.

GlaxoSmithKline and Sanofi strike massive deal with HHS for coronavirus vaccine development

Sanofi, already working with BARDA on a GlaxoSmithKline-partnered COVID-19 vaccine, has won further support from the U.S. government—this time, to the tune of $2.1 billion for clinical development and delivery of 100 million doses. It's a hefty bet, but on a proven vaccine technology from two of the biggest vaccine makers in the business.Sanofi, already working with BARDA on a GlaxoSmithKline-partnered COVID-19 vaccine, has won further support from the U.S. government—this time, to the tune of $2.1 billion for clinical development and delivery of 100 million doses. It's a hefty bet, but on a proven vaccine technology from two of the biggest vaccine makers in the business.

Top vaccine players Sanofi, GSK win $2.1B Warp Speed funding for COVID-19 shot | FiercePharma

The feds will give Sanofi and GlaxoSmithKline up to $2.1 billion to churn out a coronavirus vaccine in the Trump administration's latest and largest bet on an experimental inoculation.The feds will give Sanofi and GlaxoSmithKline up to $2.1 billion to churn out a coronavirus vaccine in the Trump administration’s latest and largest bet on an experimental inoculation. More than

US pledges $2.1B to COVID vaccine from Sanofi, GlaxoSmithKline

The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.

The deal contracts Sanofi and GlaxoKlineSmith to provide the US with enough doses of their vaccine to inoculate 50 million Americans at a price of about $42 per person - if it is effective.The deal contracts Sanofi and GlaxoKlineSmith to provide the US with enough doses of their vaccine to inoculate 50 million Americans at a price of about $42 per person - if it is effective.

US signs $2.1billion deal for 100 million doses of Sanofi, GSK vaccine | Daily Mail Online

The US government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drug makers’ testing and manufacturing, the companies said on Friday.The award is the biggest yet from ‘Operation Warp Speed’, the White House initiative aimed at accelerating access to vaccines and treatments to fight COVID-19,The US government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drug makers’ testing and manufacturing, the

US to pay $2.1b to Sanofi, GSK, in COVID-19 vaccine deal | Arab News

The U.S. award is the biggest yet from 'Operation Warp Speed', the White House initiative aimed at accelerating access to vaccines and treatments to fight COVID-19, the respiratory disease caused by the novel coronavirusThe Sanofi-GSK deal is for 100 million doses, at two per person, and gives the U.S. government an option to purchase an additional 500 million doses at an unspecified price

Biggest COVID-19 vaccine deal yet; Sanofi, GSK sign $2.1 billion deal with US govt

The head of the government's effort to develop a vaccine against COVID-19 says he expects the vaccine to have efficacy rates "in the 90%" range — but that there might not be enough vaccine available for all Americans until the end of next year.The head of the government's effort to develop a vaccine against COVID-19 says he expects the vaccine to have efficacy rates "in the 90%" range — but that there might not be enough vaccine available for all Americans until the end of next year.

Operation Warp Speed leader says he expects virus vaccine to be highly effective, 'in the 90%' range

The French drugmaker Sanofi said Friday that it had secured an agreement of up to $2.1 billion to supply the U.S. federal government with 100 million doses of its experimental coronavirus vaccine. The French drugmaker Sanofi said Friday that it had secured an agreement of up to $2.1 billion to supply the U.S. federal government with 100 million doses of its experimental coronavirus vaccine.

Sanofi, GlaxoSmithKline snag biggest coronavirus vaccine deal yet | ABS-CBN News